In a model presented at The Liver Meeting Digital Experience, experts showed that at-risk populations could be positively impacted by incremental changes in hepatitis C screening and treatment strategies.The CDC collaborative experience compared the NHANES population to the “non-NHANES” population, translating to a comparison between persons who have stable housing to those more at-risk transient populations.“It’s in this population that they nicely demonstrated there is very little impact in the care cascade. The NHANES population had improvements in screening andRead More